The lackof consistency also extends to studies examining the PPARG Pro12Ala polymorphism and cardiovascular disease events: oneprospective cohort study examining the PPARG Pro12Ala polymorphism and cardiovascular disease suggested a decreased risk ofCHD among carriers of the Ala12 allele [8], while others have shown noassociation [9,10,24] or an increase in risk [9, 25]. Here, PPARG is linked to cardiovascular disorder.